Accordingly, VTE risk is significantly elevated in a number of conditions associated with inflammation and elevations of plasma CRP levels, particularly surgery, obesity, sepsis, cancer, inflammatory bowel disease (IBD) and COVID-19. The gene discussed is CRP; the disease is obesity due to melanocortin 4 receptor deficiency.